Company Information
Industry 制造业
Company Introduction 康泰医学系统(秦皇岛)股份有限公司成立于1996年,是一家专业从事医疗诊断、监护设备的研发、生产和销售的高新技术企业。公司坐落于河北省秦皇岛市经济技术开发区,交通便利、环境适宜、配套设施完善。 公司自成立以来,始终致力于医疗诊断、监护设备的研发、生产和销售,产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,凭借良好的性能和较高的品牌知名度,已经累计销售至全球130多个国家和地区。 公司拥有完善的研发、生产和销售体系,通过了ISO9001、ISO13485质量管理体系认证、ISO14001环境管理体系认证等多项国际标准认证。公司技术力量雄厚,取得多项具有自主知识产权的核心技术专利。脉搏血氧仪、心电图机、超声多普勒胎儿心率仪、病人监护仪、多参数生命体征监测仪、电子血压计等主导产品获得中国、欧盟、美国、加拿大、巴西、日本、澳大利亚等多个国家和地区的上市许可,广泛应用于医疗机构、健康管理机构以及家庭个人保健等场合。 以人为本,创新共赢。我们将充分发挥技术、人才优势,进一步推动市场国际化、管理信息化、产品多元化,力争将康泰医学打造成为国际一流的现代化企业,实现可持续健康发展。
Main Business 医疗诊断、监护设备的研发、生产和销售
Legal Representative 胡坤
Top Executives
董事长:胡坤
董事:郑敏,杨志山
独立董事:李华,杨长东
Top 5 Shareholder
Shareholder name Nature Holding Date
胡坤限售股+流通A股46.84%30/09/2024
王桂丽流通A股12.72%30/09/2024
杨志山限售股+流通A股0.72%30/09/2024
付春元限售股+流通A股0.62%30/09/2024
寇国治限售股+流通A股0.61%30/09/2024
Company Secretary 郑敏
Solicitors 北京市中伦律师事务所
Auditors 德勤华永会计师事务所(特殊普通合伙)
Tel No 0335-8015593
Fax No 0335-8015422
Website www.contecmed.com
Email contec_sec@hotmail.com
Company Address
Register: 河北省秦皇岛市经济技术开发区秦皇西街112号
Office: 河北省秦皇岛市经济技术开发区秦皇西街112号
Listing Date 24/08/2020
Shares Capital
Shares Capital: 401,802,977
Total A Share: 401,802,977
Listed A Share: 251,569,244
Non-tradable A Share: 150,233,733
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.410
DPS(RMB)* ¥ 0.300
NBV Per Share(RMB)* ¥ 5.015
Market Capitalization(RMB) 3.696B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.